Mutant Hras^G12V and Kras^G12D have overlapping, but non‐identical effects on hepatocyte growth and transformation frequency in transgenic mice

Abstract

Background Mouse hepatocarcinogenesis is associated with mutations in Hras but infrequently in Kras. The effect on carcinogenesis of developmental age at the time of ras mutation is unknown. Aim We sought to compare quantitatively the effects of expressing mutant H- or Kras genes in fetal versus adult mouse liver. Methods We established an inducible system of gene expression in mouse liver to define disease pathogenesis associated with activation of oncogene expression. Results Diffuse expression of either oncogene in fetal or adult hepatocytes caused hepatomegaly. For mutant HrasG12V, this phenotype was almost fully reversible and accompanied by apoptosis, indicating that maintenance of hepatomegaly requires continuous HrasG12V expression. We also examined the effect of ras expression on growth of transplanted hepatocytes in an in vivo system that allows us to quantify hepatocyte growth effects in both permissive and restrictive hepatic growth environments. Mutant KrasG12D had no effect on hepatocyte growth in this sysstem. In contrast, HrasG12V induced increased hepatocyte focus growth in quiescent liver, the hallmark of a cell autonomous growth stimulus. HrasG12V also increased the fraction of donor hepatocyte foci that displayed extreme growth, a characteristic of preneoplastic lesions. Conclusions The primary effect of diffuse, whole-liver expression of either mutant ras gene in fetal or adult mouse liver is diffuse and progressive hepatic growth. HrasG12V mutation influences hepatocarcinogenesis by conferring cell autonomous growth potential upon foci of expressing cells and by increasing the risk of neoplastic progression. KrasG12D does not share these latter carcinogenic effects in mouse liver.

An approach to integrating exome sequencing for fetal structural anomalies into clinical practice

“…To our knowledge, this has only been described in mice. 19 In the case of branchio-ocular facial syndrome, absent radii has not been previously described in humans but knockout mice for TFAP2A show radial agenesis. 20 These cases demonstrate how prenatal ES expands our understanding of fetal presentations of various disorders (Table 4: ultrasound phenotypes and genotypes).…”

Mechanistic elucidation of ferroptosis and ferritinophagy: implications for advancing our understanding of arthritis

“…Instead, FINO2 exerts its effect by both indirectly inhibiting GPX4 enzymatic function and directly oxidizing iron, ultimately leading to widespread lipid peroxidation. HRAS, a mutated oncogenic RAS gene, was targeted by ML162, causing selective lethality in HRAS-expressing BJeLR cells ( Figueiredo et al, 2012 ). It has now been discovered that ML162 may not act as a direct biochemical inhibitor of GPX4, adding a layer of complexity to our understanding ( Cheff et al, 2023 ).…”

Comparison of liver oncogenic potential among human RAS isoforms

“…showed that a constitutively active form of KRAS is more tumorigenic than that of NRAS in mouse models of colon cancer, possibly explaining why mutations in KRAS are more frequently observed than NRAS in human colon tumors [ 15 ]. However, the apparent biases in mutation frequencies among the RAS genes in human cancers could be caused by factors other than differential oncogenic characteristics of RAS isoforms, such as differences in expression levels or mutation rates due to different genomic locations among the RAS genes [ 16 , 17 ].…”